GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Nanopore Technologies PLC (OTCPK:ONTTF) » Definitions » Net Current Asset Value

Oxford Nanopore Technologies (Oxford Nanopore Technologies) Net Current Asset Value : $0.46 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Nanopore Technologies Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Oxford Nanopore Technologies's net current asset value per share for the quarter that ended in Dec. 2023 was $0.46.

The historical rank and industry rank for Oxford Nanopore Technologies's Net Current Asset Value or its related term are showing as below:

ONTTF' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 2.79   Med: 5.63   Max: 9.31
Current: 2.87

During the past 6 years, the highest Price-to-Net-Current-Asset-Value Ratio of Oxford Nanopore Technologies was 9.31. The lowest was 2.79. And the median was 5.63.

ONTTF's Price-to-Net-Current-Asset-Value is ranked better than
63.19% of 1027 companies
in the Biotechnology industry
Industry Median: 3.91 vs ONTTF: 2.87

Oxford Nanopore Technologies Net Current Asset Value Historical Data

The historical data trend for Oxford Nanopore Technologies's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Nanopore Technologies Net Current Asset Value Chart

Oxford Nanopore Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Current Asset Value
Get a 7-Day Free Trial 0.08 0.18 0.99 0.75 0.46

Oxford Nanopore Technologies Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.99 0.95 0.75 0.65 0.46

Competitive Comparison of Oxford Nanopore Technologies's Net Current Asset Value

For the Biotechnology subindustry, Oxford Nanopore Technologies's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Nanopore Technologies's Price-to-Net-Current-Asset-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Oxford Nanopore Technologies's Price-to-Net-Current-Asset-Value falls into.



Oxford Nanopore Technologies Net Current Asset Value Calculation

Oxford Nanopore Technologies's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(A: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(566.054-168.622-0-0)/859.224
=0.46

Oxford Nanopore Technologies's Net Current Asset Value (NCAV) per share for the quarter that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(Q: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(566.054-168.622-0-0)/859.224
=0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford Nanopore Technologies  (OTCPK:ONTTF) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Oxford Nanopore Technologies Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Oxford Nanopore Technologies's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Nanopore Technologies (Oxford Nanopore Technologies) Business Description

Traded in Other Exchanges
Address
Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX44DQ
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The Group is primarily involved in researching, developing, manufacturing, and commercializing the world's only commercial nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables our customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science.

Oxford Nanopore Technologies (Oxford Nanopore Technologies) Headlines

From GuruFocus

Oxford Nanopore Announces Tech Updates

By ACCESSWIRE ACCESSWIRE 05-20-2022

Fastest Human Genome Sequence Uses Oxford Nanopore

By ACCESSWIRE ACCESSWIRE 01-13-2022

Genomics England Expands Nanopore Use in Cancer

By ACCESSWIRE ACCESSWIRE 04-04-2022

ONT Opens User Conference, Rich Science Programme

By ACCESSWIRE ACCESSWIRE 05-19-2022

ONT Shows New High-Accuracy, High-Output Chemistry

By ACCESSWIRE ACCESSWIRE 03-30-2022

ONT Chosen for Comprehensive Human Genome Program

By ACCESSWIRE ACCESSWIRE 05-13-2022

Oxford Nanopore Releases Short Fragment Mode

By ACCESSWIRE ACCESSWIRE 03-23-2022